Methyl 5-cyano-4-methylpyridine-2-carboxylate
CAS : 1637310-89-4
Ref. 3D-MQC31089
1g | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
Methyl 5-cyano-4-methylpyridine-2-carboxylate is a potential drug candidate for the treatment of cystic fibrosis. It has been shown to be orally bioavailable and to bind to the f508del mutation site on the CFTR protein. Methyl 5-cyano-4-methylpyridine-2-carboxylate is a member of a novel class of drugs that modulate CFTR function by binding to its phenyl groups. This compound has pharmacologic activity in vitro and may have potential as a cystic fibrosis treatment due to its stepwise mechanism and hydrophobic nature.